Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection of Concealed Cardiac Amyloidosis Using AI-ECG and CT-Derived Extracellular Volume in Patients With Atrial Fibrillation

NCT07567508 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07567508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07567508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection of Concealed Cardiac Amyloidosis Using AI-ECG and CT-Derived Extracellular Volume in Patients With Atrial Fibrillation
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
December 31, 2029
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), cardiac amyloidosis